Fig. 2

TIMELESS expression levels in human cancers. a TIMELESS expression levels in different cancer types from the TCGA database analyzed by the TIMER2.0 database. b TIMELESS expression in several cancers and paired normal tissue in the GEPIA2 database. (*P < 0.05, **P < 0.01, ***P < 0.001). c Expression of TIMELESS in different cancer cell lines analyzed by the BioGPS database. d Expression of TIMELESS in normal tissue analyzed by the BioGPS database. e Based on the CPTAC database, the expression level of TIMELESS total protein between normal tissue and primary tissue of glioblastoma multiforme, hepatocellular carcinoma, lung adenocarcinoma, UCEC, clear cell renal carcinoma and pancreatic adenocarcinoma were also analyzed. f Based on the TCGA data, the expression levels of the TIMELESS gene were analyzed by the main pathological stages (stage I, stage II, stage III, and stage IV) of ACC, KICH, KIRC, LIHC, LISC, OV, SKCM and TGCT. Log2 (TPM + 1) was applied for log-scale